Pelican Therapeutics' Grant

Pelican Therapeutics raised a round of funding on May 19, 2016. Investors include Cancer Prevention and Research Institute of Texas.

Pelican Therapeutics is developing biologic agents that represent the next generation of TNF based immunotherapy. TNFRSF25 agonists provide a CD8+ T cell and Th1-type antibody adjuvant signal when use…

Articles about Pelican Therapeutics' Grant: